At the time of writing, Vor Biopharma Inc [VOR] stock is trading at $1.97, down -1.99%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The VOR shares have lost -9.22% over the last week, with a monthly amount drifted -4.83%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Vor Biopharma Inc [NASDAQ: VOR] stock has seen the most recent analyst activity on June 30, 2025, when H.C. Wainwright upgraded its rating to a Buy but kept the price target unchanged to $3 for it. Previously, Wedbush started tracking the stock with Outperform rating on July 26, 2022, and set its price target to $18. On April 27, 2022, Goldman initiated with a Neutral rating and assigned a price target of $6 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $26 on December 17, 2021. Robert W. Baird initiated its recommendation with a Outperform and recommended $38 as its price target on December 03, 2021. Oppenheimer started tracking with a Outperform rating for this stock on December 02, 2021, and assigned it a price target of $30. In a note dated October 19, 2021, JMP Securities initiated a Mkt Outperform rating and provided a target price of $40 on this stock.
For the past year, the stock price of Vor Biopharma Inc fluctuated between $0.13 and $3.29. Currently, Wall Street analysts expect the stock to reach $3 within the next 12 months. Vor Biopharma Inc [NASDAQ: VOR] shares were valued at $1.97 at the most recent close of the market. An investor can expect a potential return of 52.28% based on the average VOR price forecast.
Analyzing the VOR fundamentals
Gross Profit Margin for this corporation currently stands at -0.54% with Operating Profit Margin at -99.67%, Pretax Profit Margin comes in at -451.55%, and Net Profit Margin reading is -451.55%. To continue investigating profitability, this company’s Return on Assets is posted at -8.1, Equity is 5.24 and Total Capital is -2.51.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.9033 points at the first support level, and at 1.8367 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.0733, and for the 2nd resistance point, it is at 2.1767.
Ratios To Look Out For
It is important to note that Vor Biopharma Inc [NASDAQ:VOR] has a current ratio of 3.49. As well, the Quick Ratio is 3.49, while the Cash Ratio is 3.24.
Transactions by insiders
Recent insider trading involved Reprogrammed Interchange LLC, 10% Owner, that happened on Aug 28 ’25 when 0.81 million shares were sold. 10% Owner, Reprogrammed Interchange LLC completed a deal on Aug 27 ’25 to sell 0.61 million shares. Meanwhile, 10% Owner Reprogrammed Interchange LLC sold 0.39 million shares on Aug 25 ’25.
